Immutep Financials

Immutep Stock Summary

Immutep competes with Zura Bio, Enveric Biosciences, Immix Biopharma, Elevation Oncology, and Design Therapeutics. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Immutep Key Financial Ratios

There are many critical financial ratios that Immutep's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Immutep Limited reports annually and quarterly.

Immutep Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Immutep's current stock value. Our valuation model uses many indicators to compare Immutep value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immutep competition to find correlations between indicators driving Immutep's intrinsic value. More Info.Immutep Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immutep's earnings, one of the primary drivers of an investment's value.

Immutep Limited Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Immutep help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immutep Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immutep Limited based on widely used predictive technical indicators. In general, we focus on analyzing Immutep Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immutep's daily price indicators and compare them against related drivers.

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.